PMID- 38378924
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240322
IS  - 1869-6953 (Print)
IS  - 1869-6961 (Electronic)
IS  - 1869-6961 (Linking)
VI  - 15
IP  - 4
DP  - 2024 Apr
TI  - Personalized Versus Non-personalized Nutritional Recommendations/Interventions 
      for Type 2 Diabetes Mellitus Remission: A Narrative Review.
PG  - 749-761
LID - 10.1007/s13300-024-01545-2 [doi]
AB  - It is a well-evidenced fact that diet significantly impacts type 2 diabetes 
      mellitus (T2DM) prevention and management. However, dietary responses vary among 
      different populations, necessitating personalized recommendations. Substantial 
      evidence supports the role of diet in T2DM remission, particularly low-energy or 
      low-carbohydrate diets that facilitate weight loss, enhance glycemic control, and 
      achieve remission. This review aims to comprehensively analyze and compare 
      personalized nutritional interventions with non-personalized approaches in T2DM 
      remission. We conducted a literature search using the Academy of Nutrition and 
      Dietetics guidelines, focusing on clinical and observational trials published 
      within the past decade. We present the strengths and drawbacks of incorporating 
      personalized nutrition into practice, along with the areas for research in 
      implementing personalized interventions, such as cost-effectiveness and 
      accessibility. The findings reveal consistently higher diabetes remission rates 
      in personalized nutrition studies compared to non-personalized interventions.
CI  - (c) 2024. The Author(s).
FAU - Arias-Marroquin, Ana T
AU  - Arias-Marroquin AT
AD  - Unidad de Investigacion de Enfermedades Metabolicas/Instituto Nacional de 
      Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.
AD  - Universidad Nacional Autonoma de Mexico, Mexico City, Mexico.
FAU - Del Razo-Olvera, Fabiola M
AU  - Del Razo-Olvera FM
AD  - Unidad de Investigacion de Enfermedades Metabolicas/Instituto Nacional de 
      Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.
AD  - Universidad Nacional Autonoma de Mexico, Mexico City, Mexico.
FAU - Castaneda-Bernal, Zaira M
AU  - Castaneda-Bernal ZM
AD  - Unidad de Investigacion de Enfermedades Metabolicas/Instituto Nacional de 
      Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.
FAU - Cruz-Juarez, Eustorgio
AU  - Cruz-Juarez E
AD  - Universidad Montrer, Morelia, Mexico.
FAU - Camacho-Ramirez, Maria F
AU  - Camacho-Ramirez MF
AD  - Universidad Autonoma del Estado de Hidalgo, Pachuca, Mexico.
FAU - Elias-Lopez, Daniel
AU  - Elias-Lopez D
AD  - Unidad de Investigacion de Enfermedades Metabolicas/Instituto Nacional de 
      Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.
FAU - Lara-Sanchez, Miguel A
AU  - Lara-Sanchez MA
AD  - Universidad Nacional Autonoma de Mexico, Mexico City, Mexico.
FAU - Chalita-Ramos, Lucia
AU  - Chalita-Ramos L
AD  - Unidad de Investigacion de Enfermedades Metabolicas/Instituto Nacional de 
      Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.
FAU - Rebollar-Fernandez, Valeria
AU  - Rebollar-Fernandez V
AD  - Unidad de Investigacion de Enfermedades Metabolicas/Instituto Nacional de 
      Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.
FAU - Aguilar-Salinas, Carlos A
AU  - Aguilar-Salinas CA
AUID- ORCID: 0000-0001-8517-0241
AD  - Unidad de Investigacion de Enfermedades Metabolicas/Instituto Nacional de 
      Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico. 
      caguilarsalinas@yahoo.com.
AD  - Universidad Nacional Autonoma de Mexico, Mexico City, Mexico. 
      caguilarsalinas@yahoo.com.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20240220
PL  - United States
TA  - Diabetes Ther
JT  - Diabetes therapy : research, treatment and education of diabetes and related 
      disorders
JID - 101539025
PMC - PMC10951170
OTO - NOTNLM
OT  - Carbohydrate-restricted
OT  - Diabetes mellitus
OT  - Diet
OT  - Dietary approaches
OT  - Glycemic control
OT  - Personalized nutrition
OT  - Type 2
COIS- Ana T. Arias-Marroquin, Fabiola M. Del Razo-Olvera, Zaira M. Castaneda-Bernal, 
      Daniel B. Elias-Lopez, Eustorgio Cruz-Juarez, Maria F. Camacho-Ramirez, Miguel A. 
      Lara-Sanchez, Lucia Chalita-Ramos, and Valeria Rebollar-Fernandez declare no 
      conflict of interest. Carlos A. Aguilar-Salinas is an Editorial Board member of 
      Diabetes Therapy. Carlos A. Aguilar-Salinas was not involved in the selection of 
      peer reviewers for the manuscript nor any of the subsequent editorial decisions.
EDAT- 2024/02/21 11:16
MHDA- 2024/02/21 11:17
PMCR- 2024/02/20
CRDT- 2024/02/21 00:01
PHST- 2024/01/05 00:00 [received]
PHST- 2024/01/31 00:00 [accepted]
PHST- 2024/02/21 11:17 [medline]
PHST- 2024/02/21 11:16 [pubmed]
PHST- 2024/02/21 00:01 [entrez]
PHST- 2024/02/20 00:00 [pmc-release]
AID - 10.1007/s13300-024-01545-2 [pii]
AID - 1545 [pii]
AID - 10.1007/s13300-024-01545-2 [doi]
PST - ppublish
SO  - Diabetes Ther. 2024 Apr;15(4):749-761. doi: 10.1007/s13300-024-01545-2. Epub 2024 
      Feb 20.